Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 43)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A MS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Banking, Mortgages & Securities Industry Market Research and Competitive Analysis 2010 501 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Banking, Mortgages & Credit Industry Trends, Statistics & Analysis 2010 (Summary) 66 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Investment & Securities Industry Almanac 2010 522 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Investment & Securities Industry Trends & Statistics 2010 (Summary) 50 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Morgan Stanley (MS) Profile & Consulting Industry Trends Analysis 2009 21 $149 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Morgan Stanley (MS) Profile & Investment and Securities Industry Trends Analysis 2010 36 $149 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A BioMS Medical 3 $25 View Abstract
6-Feb-10 Reuters Investment Profile N/A Mediaset SpA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
6-Feb-10 Reuters Investment Profile N/A BioMS Medical Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
Next 20

Brokerage Reports (Showing 1 to 3 of 3)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
27-Jan-10 Versant Partners Douglas Loe Discontinuing research coverage of BioMS 2 $10 View Abstract
20-Jan-10 Thomson StreetEvents N/A MS - Event Brief of Morgan Stanley conference call, Jan. 20, 2010 / 11:00am ET 7 $75 View Abstract
20-Jan-10 Thomson StreetEvents N/A MS - Event Transcript of Morgan Stanley conference call, Jan. 20, 2010 / 11:00am ET 24 $75 View Abstract

Independent Reports (Showing 1 to 10 of 40)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A MS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Banking, Mortgages & Securities Industry Market Research and Competitive Analysis 2010 501 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Banking, Mortgages & Credit Industry Trends, Statistics & Analysis 2010 (Summary) 66 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Investment & Securities Industry Almanac 2010 522 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Investment & Securities Industry Trends & Statistics 2010 (Summary) 50 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Morgan Stanley (MS) Profile & Consulting Industry Trends Analysis 2009 21 $149 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Morgan Stanley (MS) Profile & Investment and Securities Industry Trends Analysis 2010 36 $149 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A BioMS Medical 3 $25 View Abstract
6-Feb-10 Reuters Investment Profile N/A Mediaset SpA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
6-Feb-10 Reuters Investment Profile N/A BioMS Medical Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.